Presentation ACC 2025 STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes Presenter: Marc P. Bonaca March 29, 2025
Presentation ACC 2018 High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS Presenter: Sonia S. Anand March 11, 2018
Presentation CCVVC 2016 Calcium in the Peripheral and Coronary Arteries: The Pathologist View Presenter: Renu Virmani June 15, 2016
Presentation Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD Presenter: Thomas T. Tsai October 02, 2015
Presentation Determinants of Survival and Major AmputationAfter Peripheral Endovascular Intervention for CLI Presenter: L. Vierthaler August 04, 2015
Presentation Peripheral Arterial Disease and CLI: Still Poor Outcomes and Lack of Guideline Adherence Presenter: Holger Reinecke February 10, 2015
Presentation TCT 2014 Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Marianne Brodmann September 15, 2014
Presentation TCT 2014 DCB in BTK Intervention: Ongoing Trials and Future Perspectives Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Lawrence A. Garcia September 15, 2014
Presentation TCT 2014 CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All! Presenter: Dierk Scheinert September 15, 2014
Presentation TCT 2014 Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Peter A. Schneider September 15, 2014
Presentation TCT 2014 TCT 269: Drug-Coated Balloon vs Standard Balloon for the PTA Treatment of Lesions in the SFA and Popliteal Artery? First Interim Results of the FREERIDE Study Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Schulte Karl-Ludwig, MD September 15, 2014
Presentation TCT 2014 TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Adam Salisbury, MD September 15, 2014
Presentation TCT 2014 DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Arne Schwindt September 15, 2014
Presentation TCT 2014 DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gunnar Tepe September 15, 2014
Presentation TCT 2014 DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use? Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro September 15, 2014
Presentation TCT 2014 DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gary M. Ansel September 15, 2014
Presentation TCT 2014 DCB Use in the Real World II: DCB for Long and Highly Calcified Vessels Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gunnar Tepe September 15, 2014
Presentation TCT 2014 DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri September 15, 2014
Presentation TCT 2014 Randomized Controlled Trials I: Extended Follow-Up From LEVANT 2 - Analysis of one year Follow-up and Beyond Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri September 15, 2014